[Chapel Hill, NC, March 17, 2022] Devana Solutions, the leading cloud SaaS provider to the clinical trials industry to connect centralized research professionals to staff and clinicians at decentralized site locations, announced today that industry veteran Craig Koch has joined Devana’s Advisory Board. Koch is currently Executive Vice President of Velocity Clinical Research, a leading integrated research organization in the U.S. with global expansion now underway. Koch will join current Syneos Health Senior Vice President Tom Wollman and longtime software investor and advisor Reid Conrad currently on Devana’s Advisory Board.
“I am delighted to have Craig join our Advisory Board,” stated Barry Lake, Devana Solutions’ CEO, “Velocity Clinical Research is perhaps the most optimized organization now leveraging our advanced PROPEL enterprise platform, and Craig’s analytical skills and leadership are a big reason why. I look forward to his contributions as an advisor to Devana Solutions, particularly with the transformative development initiatives Devana will be delivering to the industry in 2023.”
“Devana Solutions’ began as a tool for clinical research sites where it will remain the gold standard for research site productivity. The flexibility of the platform and the talent of the team also position Devana to be a Solution poised to unify what is a very disjointed industry.”
Founded in 2017, Velocity has grown dramatically in the last few years and now comprises 30 research sites across the United States with current global expansion underway. The Velocity model represents a new approach to site management. By owning and operating all sites directly, the organization offers a robust infrastructure that completely integrates the sites with singular systems and processes. Their model has proven to provide consistent and predictable patient recruitment and engagement. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Koch’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics.
According to Lake, “Craig’s expertise in leveraging our technology and industry insights will be a strong addition to Devana’s Advisory Board and our company. I look forward to his contributions.”
About Devana Solutions
Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions’ innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/
About Velocity Clinical Research
Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states. Velocity places the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7,000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information. visit our website at https://velocityclinical.com.